Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Quarterly results Acq. announced Appointed director Upcoming conference date
|
PRAECIS PHARMACEUTICALS INC (PRCS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/16/2007 |
8-K
| Quarterly results |
02/16/2007 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
02/16/2007 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
02/15/2007 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
02/13/2007 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/09/2007 |
4
| SHARROCK DAVID B (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Unknown transaction of 12,750 shares
@ $5, valued at
$63.8k
Disposed/sold 4,000 options to buy
@ $4.08, valued at
$16.3k
|
|
02/09/2007 |
SC 13G/A
| DIMENSIONAL FUND ADVISORS INC reports a 6.5% stake in PRAECIS PHARMACEUTICALS INC |
02/08/2007 |
4
| ZENNER PATRICK J (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Disposed/sold 4,000 options to buy
@ $4.08, valued at
$16.3k
|
|
02/08/2007 |
4
| POST LEONARD E (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Disposed/sold 4,000 options to buy
@ $4.08, valued at
$16.3k
|
|
02/08/2007 |
4
| MCCANCE HENRY F (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Unknown transaction of 14,054 shares
@ $5, valued at
$70.3k
Disposed/sold 4,000 options to buy
@ $4.08, valued at
$16.3k
|
|
02/08/2007 |
4
| BOHLIN GAREN G (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Disposed/sold 4,000 options to buy
@ $4.08, valued at
$16.3k
|
|
02/08/2007 |
4
| WAGNER RICHARD W (EVP, Discovery Research) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Unknown transaction of 4,048 shares
@ $5, valued at
$20.2k
Disposed/sold 49,999 options to buy
@ $3.35, valued at
$167.5k
|
|
02/08/2007 |
4
| BAKER G LEONARD JR (Director) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Unknown transaction of 30,441 shares
@ $5, valued at
$152.2k
Unknown transaction of 26,185 shares
@ $5, valued at
$130.9k
Unknown transaction of 1,420 shares
@ $5, valued at
$7.1k
Unknown transaction of 3,580 shares
@ $5, valued at
$17.9k
Unknown transaction of 286,547 shares
@ $5, valued at
$1.4M
Unknown transaction of 20,572 shares
@ $5, valued at
$102.9k
Unknown transaction of 14,675 shares
@ $5, valued at
$73.4k
Disposed/sold 4,000 options to buy
@ $4.08, valued at
$16.3k
|
|
02/08/2007 |
4
| MCLAUGHLIN KEVIN F (President and CEO) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Unknown transaction of 45,000 shares
@ $5, valued at
$225k
Disposed/sold 80,000 options to buy
@ $3.35, valued at
$268k
|
|
02/08/2007 |
4
| English Edward C (VP, CFO, Treasurer & Ass. Sec.) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Unknown transaction of 1,956 shares
@ $5, valued at
$9.8k
Disposed/sold 19,999 options to buy
@ $3.35, valued at
$67k
|
|
02/08/2007 |
4
| GEFTER MALCOLM L PHD (Chairman and CSO) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Unknown transaction of 169,028 shares
@ $5, valued at
$845.1k
Unknown transaction of 1,300 shares
@ $5, valued at
$6.5k
|
|
02/07/2007 |
8-K
| Changes in Control of Registrant, Other Events, Financial Statements and Exhibits |
02/02/2007 |
SC 13G
| DIMENSIONAL FUND ADVISORS INC reports a 6.5% stake in PRAECIS PHARMACEUTICALS INC |
02/01/2007 |
8-K
| Acquisition/merger/asset purchase announced |
01/03/2007 |
SC 13D/A
| Engelberg Charles reports a 4.5% stake in PRAECIS PHARMACEUTICALS, INC. |
12/21/2006 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta... |
11/20/2006 |
SC 13D/A
| Efficacy Capital, Ltd. reports a 2.9% stake in PRAECIS PHARMACEUTICALS, INC. |
11/16/2006 |
SC 13D/A
| Engelberg Charles reports a 5.3% stake in PRAECIS PHARMACEUTICALS, INC. |
11/16/2006 |
SC 13D
| Engelberg Charles reports a 5.3% stake in PRAECIS PHARMACEUTICALS, INC. |
11/09/2006 |
10-Q
| Quarterly Report for the period ended September 30, 2006 |
11/09/2006 |
8-K
| Quarterly results |
10/10/2006 |
SC 13D
| Efficacy Capital, Ltd. reports a 9.4% stake in PRAECIS PHARMACEUTICALS, INC. |
09/05/2006 |
4
| MCLAUGHLIN KEVIN F (President and CEO) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Exercised 24,200 shares
@ $1.33, valued at
$32.2k
Exercised 24,200 options to buy
@ $0 |
|
08/04/2006 |
10-Q
| Quarterly Report for the period ended June 30, 2006 |
08/04/2006 |
8-K
| Quarterly results |
07/11/2006 |
4
| GEFTER MALCOLM L PHD (Chairman and CSO) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 40,872 shares
@ $3.01, valued at
$123k
Exercised 92,500 options to buy
@ $1.33, valued at
$123k
|
|
06/21/2006 |
4
| GARNICK MARC B (EVP and Chief Medical Officer) has filed a Form 4 on PRAECIS PHARMACEUTICALS INC
Txns:
| Disposed/sold 13,999 options to buy
@ $0 Granted 13,999 options to buy
@ $0 Disposed/sold 19,999 options to buy
@ $0 Granted 19,999 options to buy
@ $0 |
|
06/20/2006 |
8-K
| Entry into a Material Definitive Agreement, Material Impairments, Regulation FD Disclosure, Financial Statements and Exhibits |
05/08/2006 |
8-K
| Other Events, Financial Statements and Exhibits |
|
|
|